首页 | 本学科首页   官方微博 | 高级检索  
     

补体调节剂治疗骨关节炎研究进展
引用本文:汪亚娅,李妍,王福文. 补体调节剂治疗骨关节炎研究进展[J]. 食品与药品, 2021, 0(1): 80-85
作者姓名:汪亚娅  李妍  王福文
作者单位:山东省医学科学院药物研究所
基金项目:国家自然科学基金(No.81703403)。
摘    要:骨关节炎(osteoarthritis,OA)是一种关节退行性疾病.目前OA的发病机制尚不明确,但越来越多的研究表明OA与先天免疫尤其是其中的补体系统有关.降解的软骨基质可激活补体系统,生成膜攻击复合物,裂解软骨细胞,进而诱发低度炎症,最终导致OA,因此,开发补体抑制剂可能成为减缓OA发展的治疗新途径.本文基于补体激活...

关 键 词:骨关节炎  补体系统  发病机制  补体调节剂  研究进展

Research Progress of Complement Modulators in Treatment of Osteoarthritis
WANG Ya-ya,LI Yan,WANG Fu-wen. Research Progress of Complement Modulators in Treatment of Osteoarthritis[J]. Food and Drug, 2021, 0(1): 80-85
Authors:WANG Ya-ya  LI Yan  WANG Fu-wen
Affiliation:(Institute of Materia Medica,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250062,China)
Abstract:Osteoarthritis(OA)is a degenerative joint disease.The detailed pathogenesis for OA is still unclear.However,more and more evidence indicated that it could be related to innate immunity especially the complement system.The degraded cartilage matrix can activate the complement system to form the membrane attack complex(MAC)which can lead chondrocytes to death and form OA finally.Therefore,development of complement inhibitors may be a new treatment approach to slow down the development of OA.The progress and trend of complement modulators in the treatment of OA based on the mechanism of complement activation are reviewed in this paper in order to provide a new strategy for OA treatment.
Keywords:osteoarthritis  complement system  pathogenesis  complement modulator  progress
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号